Literature DB >> 1889463

Expansion and high proliferative potential of the macrophage system throughout life time of lupus-prone NZB/W and MRL lpr/lpr mice. Lack of down-regulation of extramedullar macrophage proliferation in the postnatal period.

M Müller1, A Emmendörffer, M L Lohmann-Matthes.   

Abstract

Systemic lupus erythematosus is an autoimmune disease, characterized by high titers of autoantibodies against many cell-membrane and intracellular antigens. Polyclonal B cell activation and alterations in the T cell compartment have been described. The present report deals with the organ-associated macrophage (M phi) system of two lupus-prone mouse strains (NZB/W and MRL lpr/lpr) and demonstrates that in both mouse strains the M phi compartment of liver and spleen is clearly expanded. In the liver the number of F 4/80+ M phi is strongly elevated. In addition, presence of early M phi precursors and of extramedullary organ-associated monocyte proliferation in response to colony-stimulating factor (CSF) is documented in liver and spleen of these mice. Further, in normal animals during the first two weeks of life extramedullar monocytopoiesis is present in liver and spleen, which is then down-regulated in the third week of life. In the two lupus-prone mouse strains down-regulation does not occur but extramedullar monocyte proliferation is sustained at high level throughout life time. As possible correlates for the expansion of the M phi system elevated CSF-1 mRNA levels are demonstrated in kidney, spleen and liver of NZB/W mice and elevated CSF serum levels are documented in MRL lpr/lpr mice. The possible contribution of the expanded M phi system to B and T cell dysregulation is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1889463     DOI: 10.1002/eji.1830210932

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells.

Authors:  Jiankun Zhu; Xuebin Liu; Chun Xie; Mei Yan; Ying Yu; Eric S Sobel; Edward K Wakeland; Chandra Mohan
Journal:  J Clin Invest       Date:  2005-06-09       Impact factor: 14.808

2.  Prevention of B220+ T cell expansion and prolongation of lifespan induced by Lactobacillus casei in MRL/lpr mice.

Authors:  A Mike; N Nagaoka; Y Tagami; M Miyashita; S Shimada; K Uchida; M Nanno; M Ohwaki
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

3.  Cytokine-induced monocyte characteristics in SLE.

Authors:  Zhe Zhang; Kelly Maurer; Juan C Perin; Li Song; Kathleen E Sullivan
Journal:  J Biomed Biotechnol       Date:  2010-06-24

4.  Splenic phagocytes promote responses to nucleosomes in (NZB x NZW) F1 mice.

Authors:  Akiko Okamoto; Keishi Fujio; Nico van Rooijen; Nelson H Tsuno; Koki Takahashi; Hiromichi Tsurui; Sachiko Hirose; Keith B Elkon; Kazuhiko Yamamoto
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

5.  Carbon monoxide exposure improves immune function in lupus-prone mice.

Authors:  Juan P Mackern-Oberti; Carolina Llanos; Leandro J Carreño; Sebastián A Riquelme; Sergio H Jacobelli; Ignacio Anegon; Alexis M Kalergis
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

6.  Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus.

Authors:  H B Richards; M Satoh; M Shaw; C Libert; V Poli; W H Reeves
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

7.  C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice.

Authors:  Amanda Atanasio; Vilma Decman; Derek White; Meg Ramos; Burcin Ikiz; Hoi-Ching Lee; Chia-Jen Siao; Susannah Brydges; Elizabeth LaRosa; Yu Bai; Wen Fury; Patricia Burfeind; Ralica Zamfirova; Gregg Warshaw; Jamie Orengo; Adelekan Oyejide; Michael Fralish; Wojtek Auerbach; William Poueymirou; Jan Freudenberg; Guochun Gong; Brian Zambrowicz; David Valenzuela; George Yancopoulos; Andrew Murphy; Gavin Thurston; Ka-Man Venus Lai
Journal:  Sci Rep       Date:  2016-03-16       Impact factor: 4.379

Review 8.  Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus.

Authors:  Timothy A Gottschalk; Evelyn Tsantikos; Margaret L Hibbs
Journal:  Front Immunol       Date:  2015-10-28       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.